63 indexable Clinical Genomics companies headquartered in India, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $122M across 19 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
HaystackAnalytics
Provider of genomics technology for personalized clinical decisions |
$1M | $45.6M as of 2024 |
Seed | Seed Sep 2025 | 151 | 2018 | ↑ Active |
| 2 |
CrisprBits
Developer of diagnostic tests based on gene editing technology |
$446.7K | $3.9M as of 2024 |
Seed | Seed Nov 2025 | — | 2020 | ↑ Active |
| 3 |
LifeCell
A stem cell banking company specializing in cord blood and tissue preservation |
$61.2M | $104.5M as of 2024 |
Series B | Series B Mar 2024 | 1,188 | 2004 | — |
| 4 |
Tvaster Genkalp
Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quality of life for cancer patients. |
$1.3M | $961.5K as of 2023 |
Seed | Seed Apr 2025 | 4 | 2021 | ↑ Active |
| 5 |
Datar Genetics
Provider of liquid biopsy-based cancer diagnostic test |
$742.3K | — | Early Stage | Unattributed Aug 2024 | 175 | 1992 | ↑ Active |
| 6 |
Strand Life Sciences
Strand is leading a new generation of healthcare defined by genetic insights into disease. |
$34.9M | $41.5M as of 2014 |
Acquired | Feb 2018 | 375 | 2000 | — |
| 7 |
OncoStem
Developer of prognostic tests for the detection of cancer |
$9M | — | Series A | Series A Sep 2017 | 19 | 2011 | — |
| 8 |
XCyton Diagnostics
Provider of molecular diagnostic products and services |
$5.6M | $4.9M as of 2014 |
Early Stage | Unattributed Mar 2014 | 23 | 1993 | — |
| 9 |
Indio Labs
Developers of cost-effective biomedical devices |
$5.1M | $3.1M as of 2016 |
Series A | Series A May 2016 | 9 | 2013 | — |
| 10 |
Bioheaven 360
Provider of AI-powered genomics diagnostics tools for risk prediction of diseases |
$264.4K | $1.4M as of 2022 |
Seed | Seed Jan 2023 | 5 | 2018 | — |
| 11 |
Dhiti Omics
Provides precision molecular diagnostic services |
$278.4K | $1.7M as of 2022 |
Seed | Angel Oct 2022 | — | 2014 | — |
| 12 |
Mylab
Developer of diagnostic kits for pathogen detection and viral load monitoring |
$131.5K | — | Seed | Seed Jun 2023 | 351 | 2016 | — |
| 13 |
Indna Lifesciences
Developer of DNA-based molecular detection tests and companion diagnostics for personalized medicine |
$497.2K | $1.5M as of 2019 |
Seed | Angel Sep 2019 | 1 | 2012 | — |
| 14 |
Navigene
Provider of diagnosing genetic medical conditions and recommending preventive care |
$251.1K | $1.7M as of 2020 |
Seed | Seed Oct 2020 | 16 | 2012 | — |
| 15 |
Positive Bioscience
Provider of DNA tests for cancer treatment & hereditary cancer screening |
$465.7K | $2.9M as of 2018 |
Seed | Angel Nov 2018 | 11 | 2012 | — |
| 16 |
NeoGen Labs
Neonatal diagnostic solutions for the detection of inborn errors of metabolism |
$458.3K | $976.7K as of 2011 |
Seed | Angel Mar 2011 | 25 | 2006 | — |
| 17 |
OmiX Labs
Developer of DNA testing devices for the early diagnosis and treatment of infectious diseases |
$138.1K | $1.3M as of 2021 |
Seed | Seed Jul 2020 | 10 | 2014 | — |
| 18 |
Kyvor
Genomics-based precision cancer diagnostics |
$159.8K | $1.6M as of 2017 |
Seed | Angel Jul 2017 | 11 | 2016 | — |
| 19 |
Yaathum Biotech
Provider of real-time quantitative PCR (qPCR) assays for disease diagnosis |
$16K | — | Seed | Seed Dec 2014 | 5 | 2012 | — |
| 20 |
ABC Genomics
Developer of real-time PCR device for TB and genetic marker based screening tools |
— | — | Deadpooled | — | — | 2007 | — |
| 21 |
Acton Biotech
Personalized DNA testing services |
— | — | Deadpooled | — | — | 2006 | — |
| 22 |
Adam's Genetics
Personalized genetic tests for health, wellness and fitness management |
— | — | Unfunded | — | — | 2013 | — |
| 23 |
Analyzing Biotech
Manufactures analytical clinical diagnostic instrument |
— | — | Deadpooled | — | — | 2014 | — |
| 24 |
AyuGen
Provider of genetic testing and molecular diagnostics |
— | — | Unfunded | — | — | 2005 | — |
| 25 |
Bigtec Labs
Developer of point-of-care solutions for nucleic acid amplification tests |
— | — | Funding Raised | — | 633 | 2000 | — |
| 26 |
CellMax Life
Provider of sequence-based diagnostic solutions for cancer |
— | — | Funding Raised | — | 20 | 2012 | — |
| 27 |
DeepKnomics
Developer of products in clinical diagnostics and immuno-oncology space |
— | — | Unfunded | — | — | 2019 | — |
| 28 |
Dermisgene
Provider of genomics solutions in clinical and aesthetic dermatology and trichology |
— | — | Unfunded | — | — | 2014 | — |
| 29 |
Diagopreutic
Developer of diagnostic kits for antimicrobial resistance |
— | — | Funding Raised | — | — | 2022 | — |
| 30 |
Diagright
Provider of mobile app for body vital monitoring |
— | — | Deadpooled | — | — | 2020 | — |
| 31 |
DNA Health Wellness
Provider of DNA tests for personalized dietary supplements |
— | — | Deadpooled | — | — | 2015 | — |
| 32 |
Eugene Molecular Diagnostics and Research Centre
Provider of molecular blood testing services |
— | — | Unfunded | — | — | 2017 | — |
| 33 |
FutureMed
Provider of services related to wellness, pharmacogenomics, and clinical genomics |
— | — | Unfunded | — | — | 2017 | — |
| 34 |
GeNeCaRe
Provider of genetic tests for the diagnosis of various disease conditions |
— | — | Deadpooled | — | — | 2011 | — |
| 35 |
Genecorp
Provider of diagnostic kit for genetic testing |
— | — | Deadpooled | — | — | 2016 | — |
| 36 |
Genes N Life Healthcare
Provider of molecular diagnostics and genomics research for the health care industry |
— | — | Unfunded | — | — | 2010 | — |
| 37 |
Genes2me
Provider of personalized healthcare by genetics and molecular diagnostics |
— | — | Funding Raised | — | 66 | 2016 | — |
| 38 |
Genesis Biogen
Prenatal and cancer screening tests |
— | — | Deadpooled | — | — | 2014 | — |
| 39 |
Genome Life Sciences
Provider of services for next-gen sequencing and big data analysis |
— | — | Unfunded | — | — | 2004 | — |
| 40 |
Genprot
Genome sequencing & prenatal genome sequencing services |
— | — | Deadpooled | — | — | 2015 | — |
| 41 |
HMZ Laboratories
Provider of cellular diagnostic and molecular screening |
— | — | Unfunded | — | — | 2018 | — |
| 42 |
Hotgenes
Medical diagnostics platform using DNA analysis |
— | — | Unfunded | — | — | 2013 | — |
| 43 |
inDNA
Provider of genomic analysis for routine clinical care |
— | — | Deadpooled | — | — | 2013 | — |
| 44 |
Jigsaw Bio Solutions
Malarial diagnosis by identical multi-repeat sequences |
— | — | Funding Raised | — | — | 2007 | — |
| 45 |
KnowYourGenome
Personal genomics testing company |
— | — | Deadpooled | — | — | 2011 | — |
| 46 |
Krisani Diagnostics
Provider of genomics-based molecular diagnostics |
— | — | Deadpooled | — | — | 2011 | — |
| 47 |
Lifecode Technologies
Provider of genomic diagnostic solutions and genomic technologies |
— | — | Unfunded | — | — | 2013 | — |
| 48 |
LifeGene BioScience
Provider of genetic testing, clinical genomics, and consulting services |
— | — | Deadpooled | — | — | 2009 | — |
| 49 |
LyfGene
Direct-to-consumer genetic testing |
— | — | Deadpooled | — | — | 2014 | — |
| 50 |
Mendonca Medical Biotech
Developer of miRNA biomarkers for screening and early detection of viral infections |
— | — | Deadpooled | — | — | 2017 | — |
Provider of genomics technology for personalized clinical decisions. It offers clinical-genomics diagnostic tests which include Universal Infectious Diseases Test (UID) a next-generation sequencing powered, culture-free test capable of detecting bacterial and fungal pathogens and infexn test is s a comprehensive genomic solution for rapid identification of pathogens and antimicrobial resistance directly from clinical
Developer of diagnostic tests based on gene editing technology. It offers CRISPR-based diagnostic tests for infectious diseases, inherited diseases, cancer, and predicts genetic diseases. It is also used in animal and cell models, agriculture, biofuels, therapeutics, and industries.
A stem cell banking company specializing in cord blood and tissue preservation. The company provides stem cell banking services focused on preserving umbilical cord blood and tissue stem cells for potential future medical treatments. It also offers lab tests, allografts, and skincare products through its platform.
{}
Provider of liquid biopsy-based cancer diagnostic test. The products include trublood which is a non-invasive biopsy to check for malignancy, celldx for genome analysis of tumor, exacta for personalized treatment based on tumor analysis, and chemoscale to evaluate resistance to chemotherapy drugs by in-vitro analysis.
Provider of sequence-based diagnostics and clinical genomic data interpretation services intended to identify the right therapy for cancer through genomic testing. The company's services offer informatics products and services for research biologists, chemists and toxicologists that combine advanced visualization, predictive systems modeling, data integration and scientific content management, enabling doctors to ide
Developer of prognostic tests for the detection of cancer. The company's flagship product is CanAssist-Breast, which uses a proprietary Artificial Intelligence-based statistical model to identify the patient's risk of breast cancer recurrence. Also, it provides additional information about the tumor, based on which the cancer treatment can be customized.
Provider of molecular diagnostic products and services. The company provides medical diagnosis for critical care infections, offering a wide array of immunodiagnostic and molecular diagnostic services, as well as clinical tests.
Developers of cost-effective biomedical devices. Their BioScoop biopsy system is a device for soft tissue core biopsy. It enables physicians achieve definitive tissue capture using a novel needle design, advanced needle-tissue characterization and automated control. Its other product, BxSeal is a safety feature offered to the biopsy device to assist in concurrently delivering a haemostatic agent inside the biopsy tra
Provider of AI-powered genomics diagnostics tools for risk prediction of diseases. The company uses AI and Machine Learning based patient classification model that can be used in a clinical setup for early detection and classification of osteoporosis.
Provides precision molecular diagnostic services. The company employs state-of-the-art technologies including Sanger Sequencing, Next Generation Sequencing, and Microarrays to decode an individual’s genome and identify underlying genetic clues. This help clinicians to predict, prevent and pre-empt diseases better and enables them to make an informed choice for the patients.
Developer of diagnostic kits for pathogen detection and viral load monitoring. It offers a wide range of diagnostic kits to detect and monitor a wide range of human ailments, including infections, cancer, genetic disorders, and blood screening. It offers Compact x automation solution integrates automated sample preparation and assay setup with detection, Compact xL is a sample-to-PCR ready system., and CompactQ a flu
BIRAC
C-CAMP
Department of Biotechnology
Startups at Venture Center
_1583908648608.png){kind=logo}
Brand Capital
Ecosystem Ventures
KIIT-TBI
1Crowd
ACT Grants
AIC-Pinnacle
AJ Ventures and Investments
AH
Abdul Rahman Ali Al Khudair Holding
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-25.
_1546941571490.png){kind=logo}